Science Pool

Are TripleTOFs the Future for HT-ADME/Toxicity Screening?

LC-MS provides the analytical endpoint for most discovery ADME assays. There is a constant drive to reduce LC-MS run times whilst maintaining quality. 

In this presentation, we focus on:

  • a comparison of triple quadrupole MS/MS vs TripleTOF MS
  • validation data for performance of the TripleTOF MS 
  • use of the TripleTOF in high throughput ADME screening including intrinsic clearance assays and soft spot analysis.

View the presentation to learn more!

Sounds interesting?
Enter your details below to continue reading…

By clicking on ‘Continue’ I agree that my data is being transferred to the Evotec Group. The Evotec Group currently consists of the following companies. For further details please see our Privacy Policy.

If you would like to be kept informed of our latest services, new research, events and other news please tick the box below:

Join our community

Discover the exclusive benefits on offer if you join our community.